1 | 2W8G |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-ENDO,8-ANTI)-8-BENZYL-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8-AZONIABICYCLO[3.2.1]OCTANE |
BS2 |
|
0.83 |
SHOW |
2 | 4DBM |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-exo)-8,8-dimethyl-3-(4-{[(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)oxy]methyl}-1H-1,2,3-triazol-1-yl)-8-azoniabicyclo[3.2.1]octane |
0J0 |
|
0.76 |
SHOW |
3 | 3SIO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
METHYLLYCACONITINE |
MLK |
|
0.7 |
SHOW |
4 | 3SH1 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
METHYLLYCACONITINE |
MLK |
|
0.67 |
SHOW |
5 | 2X00 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
GYMNODIMINE A |
GYN |
|
0.61 |
SHOW |
6 | 4WV9 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-exo)-8,8-dimethyl-3-[4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl]-8-azoniabicyclo[3.2.1]octane |
MD4 |
|
0.6 |
SHOW |
7 | 2XYS |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.6 |
SHOW |
8 | 5O8T |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.56 |
SHOW |
9 | 5LXB |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
palonosetron |
7A9 |
|
0.56 |
SHOW |
10 | 4ZK4 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(5R)-1-methyl-7-[5-(propan-2-yloxy)pyridin-3-yl]-1,7-diazaspiro[4.4]nonane |
TII |
|
0.55 |
SHOW |
11 | 2XNU |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
|
0.55 |
SHOW |
12 | 2YME |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
CWB |
|
0.55 |
SHOW |
13 | 5SYO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE |
C5E |
|
0.54 |
SHOW |
14 | 5O87 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.54 |
SHOW |
15 | 2WNC |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLATE |
TKT |
|
0.53 |
SHOW |
16 | 6SGV |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
Hosieine |
LDQ |
|
0.53 |
SHOW |
17 | 1UV6 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM |
CCE |
|
0.53 |
SHOW |
18 | 6QKK |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
4-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]benzamide |
H92 |
|
0.52 |
SHOW |
19 | 5KE4 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-((5-(3,7-Diazabicyclo[3.3.1]nonan-3-yl)pyridin-3-yl)oxy)-N,N-dimethylethanamine |
6S7 |
|
0.52 |
SHOW |
20 | 2YMD |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
SEROTONIN |
SRO |
|
0.52 |
SHOW |
21 | 6QQO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide |
JC8 |
|
0.52 |
SHOW |
22 | 6QQP |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-4-carboxamide |
JCW |
|
0.52 |
SHOW |
23 | 4ZRU |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-[(2S)-pyrrolidin-2-ylethynyl]pyridine |
TI9 |
|
0.52 |
SHOW |
24 | 5KZU |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
9-[[1-[8-methyl-8-(2-phenylethyl)-8-azoniabicyclo[3.2.1]octan-3-yl]triazol-4-yl]methyl]carbazole |
74S |
|
0.52 |
SHOW |
25 | 2Y57 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1R,5S)-8-PHENETHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V37 |
|
0.51 |
SHOW |
26 | 5TVC |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(E,2S)-N-methyl-5-(5-phenoxy-3-pyridyl)pent-4-en-2-amine |
7LB |
|
0.51 |
SHOW |
27 | 1UW6 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.51 |
SHOW |
28 | 4BQT |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE |
C5E |
|
0.51 |
SHOW |
29 | 5OBH |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(5S)-6,6-dimethyl-5-[(6R)-8-oxo-6,8-dihydrofuro[3,4-e][1,3]benzodioxol-6-yl]-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium |
J94 |
|
0.51 |
SHOW |
30 | 2BYQ |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
EPIBATIDINE |
EPJ |
|
0.51 |
SHOW |
31 | 5Y2Q |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-[[4-[(3,4-dichlorophenyl)methyl]piperidin-4-yl]methoxy]pyridine |
8L3 |
|
0.51 |
SHOW |
32 | 5BP0 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
5-fluoronicotine |
FN1 |
|
0.5 |
SHOW |
33 | 3ZDH |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2R)-N,N-dimethyl-4-(1-methylimidazol-2-yl)oxy-butan-2-amine |
XRS |
|
0.5 |
SHOW |
34 | 2Y56 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1S,5R)-8-[(2R)-2-HYDROXY-2-PHENYL-ETHYL]-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V11 |
|
0.5 |
SHOW |
35 | 3ZDG |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-(dimethylamino)butyl dimethylcarbamate |
XRX |
|
0.5 |
SHOW |
36 | 5AIN |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
VARENICLINE |
QMR |
|
0.5 |
SHOW |
37 | 3WTO |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine |
N2Y |
|
0.5 |
SHOW |
38 | 5FJV |
Neuronal acetylcholine receptor subunit alpha-2 | Homo sapiens |
Q15822 (ACHA2_HUMAN) |
EPIBATIDINE |
EPJ |
|
0.49 |
SHOW |
39 | 4UM3 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-(6-bromopyridin-3-yl)-1,4-diazepane |
09R |
|
0.49 |
SHOW |
40 | 5BRX |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(2R,3S,5R,7S)-2-(pyridin-3-yl)-1-azatricyclo[3.3.1.1~3,7~]decane |
TI4 |
|
0.49 |
SHOW |
41 | 4AFT |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
VARENICLINE |
QMR |
|
0.49 |
SHOW |
42 | 4FRR |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
3-[(2S)-azetidin-2-ylmethoxy]-5-[(1S,2R)-2-(2-methoxyethyl)cyclopropyl]pyridine |
0VC |
|
0.49 |
SHOW |
43 | 3WTN |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine |
N2Y |
|
0.49 |
SHOW |
44 | 3U8L |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-(5-phenylpyridin-3-yl)-1,4-diazepane |
09Q |
|
0.49 |
SHOW |
45 | 5AFJ |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.48 |
SHOW |
46 | 5OBG |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.47 |
SHOW |
47 | 5OA0 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.47 |
SHOW |
48 | 4AFH |
Achbp | Capitella teleta |
I6L8L2 (I6L8L2_CAPTE) |
Alpha-Lobeline |
L0B |
|
0.47 |
SHOW |
49 | 3WIP |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
ACETYLCHOLINE |
ACH |
|
0.46 |
SHOW |
50 | 2XZ5 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
ACETYLCHOLINE |
ACH |
|
0.45 |
SHOW |